NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000051633

Registered date:23/07/2023

Verification of the effects of continuous intake of the test food on visceral fa

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedhealthy adult men and women
Date of first enrollment2023/07/24
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Continuous intake of the test food for 12 weeks Continuous intake of control food for 12 weeks

Outcome(s)

Primary Outcomevisceral fat area
Secondary OutcomeWeight, BMI, waist circumference, hip circumference

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum60years-old
GenderMale and Female
Include criteria
Exclude criteria1.show severe allergy to the test food 2.with an implantable defibrillator such as a pacemaker 3.have a current or a history of skin diseases, 4.develop severe allergy to metals 5.with severe anemia 6.Currently pregnant or breastfeeding. Or a person who may have such a possibility during the test period 7.Liver/kidney/cardiac disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, brain disease, malignant tumor, immune disease, serious disease such as heart disease, thyroid disease, other metabolic diseases Those who have a serious current disease such as disease or a history 8.are currently undergoing drug treatment, outpatient treatment, diet therapy, or exercise therapy for any serious or chronic disease. 9.are aware of dysmenorrhea or PMS symptoms 10.using health foods, supplements, and medicines that affect test results 11.with current or past drug or alcohol dependence 12.are undergoing hospital visits due to mental disorders (depression, etc.), sleep disorders, etc., or have a history of mental disorders in the past 13.with irregular life rhythm due to night work or shift work 14.lifestyle habits may change during the period from the preliminary examination 15.with extremely irregular lifestyles such as eating and sleeping 16.have an extremely unbalanced diet 17.participated in other clinical trials (research) within 3 months prior to the date of consent acquisition, or those who plan to participate in other clinical trials (research) during the trial period 18.have collected or donated more than 200 mL of blood within 1 month or 400 mL of blood within 3 months prior to the date of obtaining informed consent 19.have difficulty keeping track of various questionnaires 20.judged to be unsuitable as subjects based on clinical test values and measured values at the time of SCR 21.are judged to be inappropriate as subjects by the principal investigator

Related Information

Contact

public contact
Name Daisuke Ochitani
Address 1-16, Kanda Nishiki-cho, Chiyoda-ku, Tokyo, Japan Japan 101-0054
Telephone 03-5281-5661
E-mail d-ochitani@bhn.co.jp
Affiliation BHN Co., Ltd EBF Business Promotion Office
scientific contact
Name Daisuke Ochitani
Address 1-16, Kanda Nishiki-cho, Chiyoda-ku, Tokyo,, Japan Japan
Telephone 03-5281-5661
E-mail d-ochitani@bhn.co.jp
Affiliation BHN Co., Ltd EBF Business Promotion Office